Uptake and metabolism of antibiotics roseoflavin and 8-demethyl-8-aminoriboflavin in riboflavin-auxotrophic Listeria monocytogenes

Journal of Bacteriology

Volumn 198, Issue 23, 2016, Pages 3233-3243

  Matern, Andreas ^a   Pedrolli, Danielle ^b   Großhennig, Stephanie ^a   Johansson, Jörgen ^c   Mack, Matthias ^a  

^a MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 NOR 8 AMINORIBOFLAVIN; 8 NOR 8 AMINORIBOFLAVIN MONONUCLEOTIDE; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; FLAVIN ADENINE NUCLEOTIDE SYNTHETASE; NUCLEOTIDE DERIVATIVE; PROTEIN LMO0728; PROTEIN LMO1329; PROTEIN LMO1945; RIBOFLAVIN DERIVATIVE; RIBOFLAVIN KINASE; ROSEOFLAVIN; ROSEOFLAVIN ADENINE DINUCLEOTIDE; ROSEOFLAVIN MONONUCLEOTIDE; SYNTHETASE; UNCLASSIFIED DRUG; 8-AMINO-8-DEMETHYLRIBOFLAVIN; ANTIINFECTIVE AGENT; RIBOFLAVIN;

ADENYLATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG METABOLISM; DRUG UPTAKE; GENE EXPRESSION REGULATION; IN VITRO STUDY; LISTERIA MONOCYTOGENES; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REPORTER GENE; RIBOSWITCH; ANALOGS AND DERIVATIVES; AUTOTROPHY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANTI-BACTERIAL AGENTS; AUTOTROPHIC PROCESSES; BACTERIAL PROTEINS; LISTERIA MONOCYTOGENES; RIBOFLAVIN;

EID: 84997207407     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00388-16     Document Type: Article

References (43)

1. Fischer M, Bacher A. 2005. Biosynthesis of flavocoenzymes. Nat Prod Rep 22: 324-350. http://dx.doi.org/10.1039/b210142b.
2. Gutiérrez-Preciado A, Torres AG, Merino E, Bonomi HR, Goldbaum FA, Garcia-Angulo VA. 2015. Extensive identification of bacterial riboflavin transporters and their distribution across bacterial species. PLoS One 10: e0126124. http://dx.doi.org/10.1371/journal.pone.0126124.
3. Eitinger T, Rodionov DA, Grote M, Schneider E. 2011. Canonical and ECF-type ATP-binding cassette importers in prokaryotes: diversity in modular organization and cellular functions. FEMS Microbiol Rev 35: 367. http://dx.doi.org/10.1111/j.1574-6976.2010.00230.x.
4. Karpowich NK, Wang DN. 2013. Assembly and mechanism of a group II ECF transporter. Proc Natl Acad Sci U S A 110: 2534-2539. http://dx.doi.org/10.1073/pnas.1217361110.
5. Langer S, Hashimoto M, Hobl B, Mathes T, Mack M. 2013. Flavoproteins are potential targets for the antibiotic roseoflavin in Escherichia coli. J Bacteriol 195: 4037-4045. http://dx.doi.org/10.1128/JB.00646-13.
6. Langer S, Nakanishi S, Mathes T, Knaus T, Binter A, Macheroux P, Mase T, Miyakawa T, Tanokura M, Mack M. 2013. The flavoenzyme azobenzene reductase AzoR from Escherichia coli binds roseoflavin mononucleotide (RoFMN) with high affinity and is less active in its RoFMN form. Biochemistry 52: 4288-4295. http://dx.doi.org/10.1021/bi400348d.
7. Pedrolli DB, Matern A, Wang J, Ester M, Siedler K, Breaker R, Mack M. 2012. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomy- ces davawensis. Nucleic Acids Res 40: 8662-8673. http://dx.doi.org/10.1093/nar/gks616.
8. Kearney EB, Goldenberg J, Lipsick J, Perl M. 1979. Flavokinase and FAD synthetase from Bacillus subtilis specific for reduced flavins. J Biol Chem 254: 9551-9557.
9. Mashhadi Z, Xu H, Grochowski LL, White RH. 2010. Archaeal RibL: a new FAD synthetase that is air sensitive. Biochemistry 49: 8748 -8755. http://dx.doi.org/10.1021/bi100817q.
10. Fraaije MW, Mattevi A. 2000. Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem Sci 25: 126 -132. http://dx.doi.org/10.1016/S0968-0004(99)01533-9.
11. Macheroux P, Kappes B, Ealick SE. 2011. Flavogenomics-a genomic and structural view of flavin-dependent proteins. FEBS J 278: 2625-2634. http://dx.doi.org/10.1111/j.1742-4658.2011.08202.x.
12. Bennett BD, Kimball EH, Gao M, Osterhout R, Van Dien SJ, Rabinow- itz JD. 2009. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol 5: 593-599. http://dx.doi.org/10.1038/nchembio.186.
13. Otani S, Takatsu M, Nakano M, Kasai S, Miura R. 1974. Lett: Roseoflavin, a new antimicrobial pigment from Streptomyces. J Antibiot (Tokyo) 27: 88-89. http://dx.doi.org/10.7164/antibiotics.27.88.
14. Schwarz J, Konjik V, Jankowitsch F, Sandhoff R, Mack M. 2016. Identification of the key enzyme of roseoflavin biosynthesis. Angew Chem Int Ed Engl 55: 6103-6106. http://dx.doi.org/10.1002/anie.201600581.
15. Jankowitsch F, Kuhm C, Kellner R, Kalinowski J, Pelzer S, Macheroux P, Mack M. 2011. A novel N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase (RosA) catalyzing the two terminal steps of roseoflavin biosynthesis in Streptomyces davawensis. J Biol Chem 286: 38275-38285. http://dx.doi.org/10.1074/jbc.M111.292300.
16. Tongsook C, Uhl MK, Jankowitsch F, Mack M, Gruber K, Macheroux P. 2016. Structural and kinetic studies on RosA, the enzyme catalysing the methylation of8-demethyl-8-amino-D-riboflavin to the antibiotic roseo- flavin. FEBS J 283: 1531-1549. http://dx.doi.org/10.1111/febs.13690.
17. Mansjö M, Johansson J. 2011. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection. RNA Biol 8: 674-680. http://dx.doi.org/10.4161/rna.8.4.15586.
18. Pedrolli DB, Nakanishi S, Barile M, Mansurova M, Carmona EC, Lux A, Gartner W, Mack M. 2011. The antibiotics roseoflavin and 8-demethyl-8-amino-riboflavin from Streptomyces davawensis are metabolized by human flavokinase and human FAD synthetase. Biochem Pharmacol 82: 1853-1859. http://dx.doi.org/10.1016/j.bcp.2011.08.029.
19. 2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum. J Bacteriol 189: 7367-7375. http://dx.doi.org/10.1128/JB.00590-07.
20. Goulas T, Cuppari A, Garcia-Castellanos R, Snipas S, Glockshuber R, Arolas JL, Gomis-Ruth FX. 2014. The pCri System: a vector collection for recombinant protein expression and purification. PLoS One 9: e112643. http://dx.doi.org/10.1371/journal.pone.0112643.
21. Ott E, Stolz J, Lehmann M, Mack M. 2009. The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol 6: 276-280. http://dx.doi.org/10.4161/rna.6.3.8342.
22. Phan-Thanh L, Gormon T. 1997. A chemically defined minimal medium for the optimal culture of Listeria. Int J Food Microbiol 35: 91-95. http://dx.doi.org/10.1016/S0168-1605(96)01205-6.
23. Pedrolli DB, Mack M. 2014. Bacterial flavin mononucleotide riboswitches as targets for flavin analogs. Methods Mol Biol 1103: 165-176. http://dx.doi.org/10.1007/978-1-62703-730-3_13.
24. Löw C, Jegerschöld C, Kovermann M, Moberg P, Nordlund P. 2012. Optimisation of over-expression in E. coli and biophysical characterisation of human membrane protein synaptogyrin 1. PLoS One 7: e38244. http://dx.doi.org/10.1371/joumal.pone.0038244.
25. Karpowich NK, Song JM, Cocco N, Wang DN. 2015. ATP binding drives substrate capture in an ECF transporter by a release-and-catch mechanism. Nat Struct Mol Biol 22: 565-571. http://dx.doi.org/10.1038/nsmb.3040.
26. Mack M, van Loon AP, Hohmann HP. 1998. Regulation of riboflavin biosynthesis in Bacillus subtilis is affected bythe activity of the flavokinase/ flavin adenine dinucleotide synthetase encoded by ribC. J Bacteriol 180: 950-955.
27. Herguedas B, Martinez-Julvez M, Frago S, Medina M, Hermoso JA. 2010. Oligomeric state in the crystal structure of modular FAD synthetase provides insights into its sequential catalysis in prokaryotes. J Mol Biol 400: 218-230. http://dx.doi.org/10.1016/j.jmb.2010.05.018.
28. Barthelmes J, Ebeling C, Chang A, Schomburg I, Schomburg D. 2007. BRENDA, AMENDA and FRENDA: the enzyme information system in 2007. Nucleic Acids Res 35: D511-D514. http://dx.doi.org/10.1093/nar/gkl972.
29. Wurtzel O, Sesto N, Mellin JR, Karunker I, Edelheit S, Becavin C, Archambaud C, Cossart P, Sorek R. 2012. Comparative transcriptomics of pathogenic and non-pathogenic Listeria species. Mol Syst Biol 8: 583. http://dx.doi.org/10.1038/msb.2012.11.
30. Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS. 2002. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res 30: 3141-3151. http://dx.doi.org/10.1093/nar/gkf433.
31. Pedrolli D, Langer S, Hobl B, Schwarz J, Hashimoto M, Mack M. 2015. The ribB FMN riboswitch from Escherichia coli operates at the transcriptional and translational level and regulates riboflavin biosynthesis. FEBS J 282: 3230-3242. http://dx.doi.org/10.1111/febs.13226.
32. Mraheil MA, Billion A, Mohamed W, Mukherjee K, Kuenne C, Pischimarov J, Krawitz C, Retey J, Hartsch T, Chakraborty T, Hain T. 2011. The intracellular sRNA transcriptome of Listeria monocytogenes during growth in macrophages. Nucleic Acids Res 39: 4235-4248. http://dx.doi.org/10.1093/nar/gkr033.
33. Abbas CA, Sibirny AA. 2011. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev 75: 321-360. http://dx.doi.org/10.1128/MMBR.00030-10.
34. Rodionov DA, Hebbeln P, Eudes A, ter Beek J, Rodionova IA, Erkens GB, Slotboom DJ, Gelfand MS, Osterman AL, Hanson AD, Eitinger T. 2009. A novel class of modular transporters for vitamins in prokaryotes. J Bacteriol 191: 42-51. http://dx.doi.org/10.1128/JB.01208-08.
35. Jankowitsch F, Schwarz J, Ruckert C, Gust B, Szczepanowski R, Blom J, Pelzer S, Kalinowski J, Mack M. 2012. Genome sequence of the bacterium Streptomyces davawensis JCM 4913 and heterologous production of the unique antibiotic roseoflavin. J Bacteriol 194: 6818 -6827. http://dx.doi.org/10.1128/JB.01592-12.
36. Grill S, Busenbender S, Pfeiffer M, Kohler U, Mack M. 2008. The bifunctional flavokinase/flavin adenine dinucleotide synthetase from Streptomyces davawensis produces inactive flavin cofactors and is not involved in resistance to the antibiotic roseoflavin. J Bacteriol 190: 1546 - 1553. http://dx.doi.org/10.1128/JB.01586-07.
37. Yruela I, Arilla-Luna S, Medina M, Contreras-Moreira B. 2010. Evolutionary divergence ofchloroplast FAD synthetase proteins. BMC Evol Biol 10: 311. http://dx.doi.org/10.1186/1471-2148-10-311.
38. Pedrolli DB, Kuhm C, Sevin DC, Vockenhuber MP, Sauer U, Suess B, Mack M. 2015. A dual control mechanism synchronizes riboflavin and sulphur metabolism in Bacillus subtilis. Proc Natl Acad Sci U S A 112: 14054-14059. http://dx.doi.org/10.1073/pnas.1515024112.
39. Herguedas B, Lans I, Sebastian M, Hermoso JA, Martinez-Julvez M, Medina M. 2015. Structural insights into the synthesis of FMN in prokaryotic organisms. Acta Crystallogr D Biol Crystallogr 71: 2526 -2542. http://dx.doi.org/10.1107/S1399004715019641.
40. Akompong T, Ghori N, Haldar K. 2000. In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 44: 88-96. http://dx.doi.org/10.1128/AAC.44.1.88-96.2000.
41. Pedrolli DB, Jankowitsch F, Schwarz J, Langer S, Nakanishi S, Frei E, Mack M. 2013. Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistance. Curr Pharm Des 19: 2552-2560. http://dx.doi.org/10.2174/1381612811319140006.
42. Pedrolli DB, Jankowitsch F, Schwarz J, Langer S, Nakanishi S, Mack M. 2014. Natural riboflavin analogs. Methods Mol Biol 1146: 41-63. http://dx.doi.org/10.1007/978-1-4939-0452-5_3.
43. Skliarova SA, Kreneva RA, Perumov DA, Mironov AS. 2012. The characterization ofinternal promoters in the Bacillus subtilis riboflavin biosynthesis operon. Genetika 48: 1133-1141. (In Russian.)